Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Insulin, Long-Acting

Known as: Long Acting Insulin, Insulin, Long-Acting [Chemical/Ingredient], Insulin, Long Acting 
Insulin formulations that contain substances that retard absorption thus extending the time period of action.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Insulin degludec (IDeg) is a new‐generation, ultra‐long‐acting basal insulin that forms soluble multihexamers upon subcutaneous… Expand
Is this relevant?
Highly Cited
2012
Highly Cited
2012
The application of poly(hydroxybutyrate-co-hydroxyhexanoate) (PHBHHx) for sustained and controlled delivery of hydrophilic… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Review
2009
Review
2009
Aim:  Basal insulin in type 1 diabetes can be provided using either NPH (Neutral Protamine Hagedorn) human insulin or long‐acting… Expand
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Aim: The Helping Evaluate Exenatide in overweight patients with diabetes compared with Long‐Acting insulin (HEELA) study was… Expand
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Added to oral agents, it may eventually replace injections 
Is this relevant?
Highly Cited
2004
Highly Cited
2004
OBJECTIVE Glycemic control using inhaled, dry-powder insulin plus a single injection of long-acting insulin was compared with a… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
OBJECTIVE To study the pharmacodynamic properties of the subcutaneously injected long-acting insulin analog HOE901 (30 microg/ml… Expand
  • figure 1
  • figure 2
  • table 1
Is this relevant?
Highly Cited
2000
Highly Cited
2000
NN304 is a long-acting insulin analogue that is acylated with a 14-C-fatty acid chain. Protraction of action of this novel… Expand
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Aims To compare the pharmacokinetic and pharmacodynamic properties of subcutaneously injected NN304, a novel long‐acting insulin… Expand
Is this relevant?
Highly Cited
1988
Highly Cited
1988
Evidence is accumulating that a non‐GH dependent insulin‐like growth factor‐binding protein (IGF‐BP) is not only a carrier… Expand
Is this relevant?